EMID1 anticorps (AA 351-441) (Biotin)
-
- Antigène Tous les produits EMID1
- EMID1 (EMI Domain Containing 1 (EMID1))
-
Épitope
- AA 351-441
-
Reactivité
- Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EMID1 est conjugé à/à la Biotin
-
Application
- ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Réactivité croisée
- Rat
- Homologie
- Human,Mouse,Dog,Cow
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human EMID1
- Isotype
- IgG
-
-
- Indications d'application
-
IHC-P 1:200-400
IHC-F 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- EMID1 (EMI Domain Containing 1 (EMID1))
- Autre désignation
- EMID1 (EMID1 Produits)
- Synonymes
- anticorps EMI5, anticorps EMU1, anticorps AW122071, anticorps CO-5, anticorps Emu1, anticorps RGD1565846, anticorps EMI domain containing 1, anticorps EMID1, anticorps Emid1
- Sujet
-
Synonyms: AW122071, CO 5, CTA-984G1.2, EMI domain containing 1, EMI domain containing protein 1, EMI domain-containing protein 1, EMI5, EMID 1, Emid1, EMID1_HUMAN, Emilin and multimerin domain containing protein 1, Emilin and multimerin domain-containing protein 1, EMU1, hEmu1, MGC50657, OTTMUSP00000005297, Protein Emu1, Putative emu1, RGD1565846, RP23-338J18.3.
Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.
- ID gène
- 129080
- UniProt
- Q96A84
-